Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Phase: Phase 1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Humans%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Humans%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Humans%22&type=Subject
PubPharm (729)
1
A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults : A Phase 1 Randomized, Observer-blind, Dose-escalation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of an mRNA-based Monovalent Influenza Vaccine Candidate in Healthy Younger and Older Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying mRNA Influenza Vaccine in Healthy Adults : Phase 1, Randomized, Placebo-Controlled, Observer Blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of an Investigational Self-Amplifying mRNA Influenza Vaccine in Healthy Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults : VRC 326 (001614): A Phase I Open-Label Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza : A PHASE 1, RANDOMIZED, OBSERVER-BLIND, DOSE-RANGING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MODIFIED RNA VACCINE CANDIDATES AGAINST PANDEMIC INFLUENZA IN HEALTHY INDIVIDUALS 18 THROUGH 49 YEARS OF AGE
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Covid-19 and Influenza Oral Vaccine Study : A Binded, Randomised, Controlled Cross-over Trial to Assess the Safety and Efficacy of Mucosal Covid-19 and Influenza Vaccines
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model : Dose-Escalation Study of a Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above. : A Randomized, Double-blind, Controlled Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model : Dose-Escalation Study of a Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above. : A Randomized, Double-blind, Controlled Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Flublok or Fluzone With Advax-CpG55.2 or AF03 : A Phase I Study to Assess the Safety, Reactogenicity and Immunogenicity of Two Quadrivalent Seasonal Influenza Vaccines (Fluzone(R) or Flublok(R)) With or Without One of Two Adjuvants (AF03 or Advax-CpG55.2) in Healthy Adults 18-45 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[73]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 1
Medienart
729
Aufsätze
729
E-Artikel
729
E-Ressourcen
Zeitschriftentitel
467
ClinicalTrials.gov
262
WHO International Clinical Trials Registry Plat...
Thema
729
610
Phase: Phase 1
723
Study Type: Interventional
460
Recruitment Status: Completed
294
Influenza, Human
120
HIV Infections
118
Acquired Immunodeficiency Syndrome
115
Medical Condition: Influenza
75
Recruitment Status: Not yet recruiting
60
Recruitment Status: Recruiting
58
Recruitment Status: Authorised-recruitment may ...
51
Medical Condition: Infection, Human Immunodefic...
43
Influenza in Birds
23
Communicable Diseases
22
Infection
18
Recruitment Status: Active, not recruiting
17
Medical Condition: Influenza, Human
15
Medical Condition: Human Immunodeficiency Virus
14
Virus Diseases
13
Recruitment Status: Terminated
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
320
2020-
386
2010-2019
23
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
727
Englisch
2
Spanisch
Haven't found what you're looking for?
Wird geladen...